NLS Pharmaceutics (NLSP) said Friday that Kadimastem's shareholders have approved the company's merger with NLS.
NLS said it is also planning to hold a shareholder meeting for final approval of the deal.
NLS shares were up 45% in recent trading.
Price: 2.88, Change: +0.90, Percent Change: +45.45
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。